Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

Zofran

zofran

Zofran (ondansetron) is an antiemetic drug, used to treat and prevent nausea and vomiting. It was the first in a class of drugs called serotonin-3 (5-HT3) receptor antagonists to receive meant to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy and surgery. It is not and never has been approved for use in pregnant women, but for many years it was prescribed off-label to treat nausea and vomiting of pregnancy (NVP).

Zofran Uses

Zofran was approved by the U.S. Food and Drug Administration (FDA) in 1991. It is approved for the following uses:

  • Prevent nausea and vomiting caused by chemotherapy treatment for cancer
  • Prevent nausea and vomiting caused by radiation therapy
  • Prevent post-surgical nausea and vomiting

Zofran Side Effects

The following side effects have been associated with Zofran use:

  • Serotonin syndrome
  • QT prolongation
  • Blurred vision
  • Temporary vision loss
  • Severe dizziness
  • Shortness of breath
  • Difficulty breathing
  • Fainting
  • Fast or pounding heartbeats
  • Slow heart rate
  • Anxiety
  • Agitation
  • Shivering
  • Fainting
  • Seizures
  • Urinating less than usual or not at all
  • Diarrhea
  • Constipation
  • Fever
  • Headache

Serotonin syndrome occurs when high levels of serotonin accumulate in your body. It is a medical emergency and can be life-threatening.

QT prolongation is an electrical disturbance in the heart that can cause serious irregular heart rhythms. It can be fatal.

Zofran Off-Label

The FDA only approves drugs for specific purposes. When a drug is used for any other purpose, it is referred to as “off-label”. Doctors are allowed to prescribe drugs off-label, when they feel it is in the best interests of their patients. Drug companies, on the other hand, are not allowed to market their products for off-label purposes.

Zofran is sometimes prescribed off-label to treat acute gastroenteritis in children.

For many years, Zofran was also prescribed off-label to treat morning sickness in pregnant women. In 2012, the manufacturer reached a settlement agreement with the government regarding the marketing of several pharmaceutical products. There were no findings that the manufacturer illegally marketed Zofran and the manufacturer did not admit wrongdoing or agree to plead guilty with respect to the marketing of Zofran.

Dangers of Zofran Use in Pregnancy

Zofran use during pregnancy can cause harm to the fetus and birth defects including:

  • Fetal death
  • Fetal growth restriction
  • Congenital heart malformations
  • Hypospadias
  • Heart murmurs
  • Orofacial clefts
  • Skeletal abnormalities
  • Skull deformities
  • Kidney malformation
  • Jaundice
  • Clubbed foot
  • Vision problems
  • Hearing loss

If you have questions about Zofran that are not answered here or believe your child’s birth defect was caused by Zofran, please email us.  We will help you find answers to your questions and we can refer you to an attorney who represents families of children with birth defects.

Share this:

  • Facebook
  • LinkedIn
  • Twitter

RSS FDA Med Watch

  • Alert: Automated Impella Controller Correction due to Cybersecurity Issue from Abiomed
  • FDA Approves Labeling Changes that Include a Boxed Warning for Immune Effector Cell-associated Enterocolitis Following Treatment with Ciltacabtagene Autoleucel (CARVYKTI, Janssen Biotech, Inc.)
  • Trividia Health, Inc. Initiates Voluntary Recall of Limited Number of TRUE METRIX® Blood Glucose Meters
  • Endoscopic Aspiration Needle Recall: Olympus Removes Certain ViziShot 2 FLEX (19G) Needles Due to Potentially Deformed A-traumatic Tips
  • What is a Medical Device Recall?
  • Update on Alert: Infusion Set Performance Issue from BD
  • Recall and Alert Resources

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Belviq Withdrawn Due to Cancer Risk
  • Common Heartburn Medication may lead to bladder, stomach, and other cancers. Zantac Lawsuits begin.
  • J&J Settles Talc Mesothelioma Settlement

RSS Lawsuits and Settlements

  • Possible Lawsuit: Suboxone Tooth Decay Legal News and Lawsuit Information
  • Possible Lawsuit: Ozempic and Mounjaro Weight Loss Lawsuit News and Legal Information
  • Possible Lawsuit: CPAP Lung Cancer Lawsuit News and Legal Information

RSS Mass Tort News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Health Industry

  • High Court Won't Hear FDA Stem Cell Regulation Fight
  • Ex-Temple Worker Can Sue Under ADA, Not As Whistleblower
  • Federal Worker Unions Press For Immediate Block Of Layoffs

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2025 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in